previous compound ID: 1947 next compound
InChIKey: RICLFGYGYQXUFH-UHFFFAOYSA-N
SMILES: C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "R Robert" "DY Thomas" "J Liao" "D Rotin" "GW Carlile" "J Goepp" "E Matthes" "B Kus" "SD Macknight"

chemical graph of compound 1947





CID is 36431
synonyms found at PubChem are:
Buspirone hydrochloride, 33386-08-2, Buspar, Buspirone HCL, Narol, Buspimen, Ansitec, Anxinil, Anxiolan, Busirone, Buspinol, Censpar, Effiplen, Establix, Kallmiren, Lucelan, Mabuson, Normaton, Spamilan, Barpil, Itagil, Nerbet, Sburol, Travin, Tutran, Biron, Relac, Apo-Buspirone, Bespar, Buspirone (hydrochloride), UNII-207LT9J9OC, EINECS 251-489-4, MJ 9022-1, MLS000069796, 207LT9J9OC, CHEBI:3224, 8-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-8-azaspiro[4.5]decane-7,9-dione hydrochloride, N-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-1,1-cyclopentanediacetamide monohydrochloride, SMR000058186, Buspar (TN), 1,1-Cyclopentanediacetimide, N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, hydrochloride, 8-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione hydrochloride, 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride, 8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione hydrochloride, N-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride, C21H32ClN5O2, 8-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione monohydrochloride, 8-Azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, monohydrochloride, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione, SR-01000075541, Buspirone hydrochloride [USAN], 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochloride, Prestwick_711, Buspirone hydrochloride [USAN:USP], Opera_ID_707, AC1L1VQO, AC1Q3EKR, SCHEMBL41495, MLS001076085, MLS002548862, C21H31N5O2.HCl, Buspirone hydrochloride (USP), Jsp006125, CHEMBL1200399, DTXSID1037193, CTK8F8364, MolPort-002-163-732, RICLFGYGYQXUFH-UHFFFAOYSA-N, HMS1569I19, Pharmakon1600-02300173, APC-6002, APC-6003, BCP28463, HY-B1115, Tox21_500223, MFCD00078569, NSC751138, NSC759571, s4256, AKOS015962019, AC-1905, CCG-213652, CS-4714, H05B847, KS-5163, LP00223, MCULE-3504513666, NC00673, NSC-751138, NSC-759571, VA10444, KS-000018A2, NCGC00093692-01, NCGC00093692-02, NCGC00260908-01, AN-14507, BC228667, CPD000058186, LS-22724, SAM002264597, EU-0100223, FT-0623290, ST51014924, B 7148, D00702, J10144, K-7699, Q-200768, SR-01000075541-1, SR-01000075541-3, SR-01000075541-7, Buspirone Hydrochloride 1.0 mg/ml in Methanol (as free base), Buspirone hydrochloride, European Pharmacopoeia (EP) Reference Standard, Buspirone hydrochloride, United States Pharmacopeia (USP) Reference Standard, 8-[4-(4-pyrimidin-2-ylpiperazinyl)butyl]-8-azaspiro[4.5]decane-7,9-dione, chlo ride, 8-Azaspiro(4,5)decane-7,9-dione,8-(4-(4-(2-pyrimidinyl)piperizinyl)butyl), 8-Azaspiro[4.5]decane-7, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, monohydrochloride, Buspirone for system suitability, European Pharmacopoeia (EP) Reference Standard, N-[4-(4-[2-Pyrimidinyl]-1-piperazinyl)butyl]-8-azaspiro[4, 5]decane-7, 9-dione, 1-[4-(7,9-dioxo-8-azaspiro[4.5]decan-8-yl)butyl]-4-(pyrimidin-2-yl)piperazin-1-ium chloride, 8-[4-[4-(2-Pyrimidinyl)-1-pipirazinyl]butyl]-8-azaspiro[4,5]decane-7,9-dione hydrochloride, 8-[4-[4-(pyrimidine-2-yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7,9-dione hydrochloride, 8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-,monohydrochloride, Buspirone hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, AKOS026750365, MolPort-000-733-642